Compare USBC & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | USBC | TOI |
|---|---|---|
| Founded | N/A | 2007 |
| Country | | United States |
| Employees | 6 | N/A |
| Industry | | Medical/Nursing Services |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 333.2M | 346.3M |
| IPO Year | N/A | N/A |
| Metric | USBC | TOI |
|---|---|---|
| Price | $0.69 | $3.66 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | N/A | ★ 1.6M |
| Earning Date | N/A | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $461,039,000.00 |
| Revenue This Year | N/A | $28.51 |
| Revenue Next Year | N/A | $23.54 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 21.67 |
| 52 Week Low | N/A | $0.21 |
| 52 Week High | N/A | $4.88 |
| Indicator | USBC | TOI |
|---|---|---|
| Relative Strength Index (RSI) | 40.94 | 54.74 |
| Support Level | $0.68 | $3.23 |
| Resistance Level | $0.74 | $3.90 |
| Average True Range (ATR) | 0.06 | 0.23 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 10.04 | 65.10 |
USBC Inc is a non-invasive medical diagnostics. The group is focused on the development and commercialization of proprietary sensor technology utilizing radio and microwave dielectric spectroscopy. Its Sensor technology elicits a dielectric response that is different for every molecule. The group considers the business to currently have one operating segment: the development of its radio frequency spectroscopy technology, with a first focus on non-invasively ascertaining blood glucose levels.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.